Abstract
Perifosine Plus Bortezomib and Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients Previously Treated with Bortezomib: Final Results of a Phase I/II Trial
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have